Portuguese index of access to hospital medicines 2021 – an improved indicator
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: HMI-001
- By: ADVINHA, Ana Margarida (CHRC - Comprehensive Health Research Centre, Portugal)
- Co-author(s): Prof Ana Margarida Advinha, Professor (CHRC - Comprehensive Health Research Centre, Évora, Portugal / Universidade de Évora, Évora, Portugal)
Dr Miguel Lopes (APAH - Associação Portuguesa de Administradores Hospitalares, Lisboa, Portugal)
Dr Alexandra Santos (APAH - Associação Portuguesa de Administradores Hospitalares, Lisboa, Portugal)
Prof Sofia Oliveira-Martins, Auxiliary Professor (CHRC - Comprehensive Health Research Centre, Évora, Portugal / Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal)
Background: Medicines are largely responsible for increasing life expectancy and improving quality of life. Access to innovative and/or effective medication is a citizen’s right. It is therefore important to identify barriers to their access, particularly within the NHS, to minimize existing barriers and inequalities in access.
The WHO defines.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019